Late-onset cerebellar degeneration in mice induced transplacentally by methylnitrosourea.

A late-onset degenerative disease in the cerebellum was produced in the offspring of mice exposed to 1 mg/kg of the direct-acting DNA alkylating agent methylnitrosourea (MNU) on day 16 of gestation. This intrauterine exposure to MNU also provoked a progressive retinal degeneration that was described elsewhere. Mild ataxia in the MNU-exposed animals was expressed by 20 weeks of age. Although animals appeared normal in the immediate post-natal period, quantitative histological evaluation of cerebellar coronal sections indicated that MNU-exposed animals had a significantly greater number of pyknotic Purkinje cells than age-matched controls. The number of pyknotic Purkinje cells declined with age in the drug exposed animals; however, the percentage of pyknotic Purkinje cells to total number of Purkinje cells still was greater in MNU-induced animals at 36 weeks than in controls, suggesting that a slow degenerative process was ongoing in the MNU-exposed animals. Furthermore, the folia were grossly disrupted in 90% of the older MNU-exposed animals (ages greater than 12 weeks), suggesting permanent cerebellar disruption macroscopically. Such intrauterine exposure to low doses of alkylating agents may be potentially useful in modeling degenerative neuronal diseases.

[1]  K. L. Yielding,et al.  Retinal degeneration in the mouse. A model induced transplacentally by methylnitrosourea. , 1986, Experimental eye research.

[2]  R. J. Mullen,et al.  Retinal degeneration in the pcd cerebellar mutant mouse. II. Electron microscopic analysis , 1982, The Journal of comparative neurology.

[3]  R. J. Mullen,et al.  Retinal degeneration in the pcd cerebellar mutant mouse. I. Light microscopic and autoradiographio analysis , 1982, The Journal of comparative neurology.

[4]  K. L. Yielding,et al.  Focal cerebellar dystrophy caused by transplacental administration of methylnitrosourea , 1982, Brain Research Bulletin.

[5]  D. Ingram,et al.  Differential effects of age on motor performance in two mouse strains , 1981, Neurobiology of Aging.

[6]  J. Miquel,et al.  A simple technique for evaluation of vitality loss in aging mice, by testing their muscular coordination and vigor , 1978, Experimental Gerontology.

[7]  G. D. Das,et al.  EXPERIMENTAL STUDIES ON THE POSTNATAL DEVELOPMENT OF THE BRAIN. III. CEREBELLAR DEVELOPMENT FOLLOWING LOCALIZED ADMINISTRATION OF ENU , 1977 .

[8]  R. J. Mullen,et al.  Purkinje cell degeneration, a new neurological mutation in the mouse. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. J. Mullen,et al.  Two new types of retinal degeneration in cerebellar mutant mice , 1975, Nature.

[10]  D. Woodward,et al.  Purkinje cell dendritic alterations after transient developmental injury of the external granular layer , 1975, Brain Research.

[11]  H. M. Dembitzer,et al.  THE FINE STRUCTURE OF STAGGERER CEREBELLUM , 1975, Journal of neuropathology and experimental neurology.

[12]  G. D. Das,et al.  Teratologic effects of ethylnitrosourea on brain development in rats. , 1974, Teratology.

[13]  J. François Tapetoretinal Degenerations in Spinocerebellar Degenerations (Heredoataxias) , 1974 .

[14]  P. Rakić,et al.  Organization of cerebellar cortex secondary to deficit of granule cells in weaver mutant mice , 1973, The Journal of comparative neurology.

[15]  S. Landis ULTRASTRUCTURAL CHANGES IN THE MITOCHONDRIA OF CEREBELLAR PURKINJE CELLS OF NERVOUS MUTANT MICE , 1973, The Journal of cell biology.

[16]  H. Meier,et al.  Three syndromes produced by two mutant genes in the mouse. Clinical, pathological, and ultrastructural bases of tottering, leaner, and heterozygous mice. , 1971, The Journal of heredity.

[17]  R. E. Smith,et al.  Retinopathy associated with hereditary olivopontocerebellar degeneration. , 1971, American journal of ophthalmology.

[18]  R. Sidman,et al.  Atlas of the Mouse Brain and Spinal Cord , 1971 .

[19]  H. Minagi,et al.  Familial nephropathy associatdd with retinitis pigmentosa, cerebellar ataxia and skeletal abnormalities. , 1970, The American journal of medicine.

[20]  J. DiPaolo TERATOGENIC AGENTS: MAMMALIAN TEST SYSTEMS AND CHEMICALS , 1969 .

[21]  H. Tsukagoshi,et al.  Hereditary muscular atrophy with ataxia, retinitis pigmentosa, and diabetes mellitus , 1968, Neurology.

[22]  E. Gehan A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[23]  M. Hamburgh ANALYSIS OF THE POSTNATAL DEVELOPMENTAL EFFECTS OF "REELER," A NEUROLOGICAL MUTATION IN MICE. A STUDY IN DEVELOPMENTAL GENETICS. , 1963, Developmental biology.

[24]  R. Sidman,et al.  An autoradiographic analysis of histogenesis in the mouse cerebellum. , 1961, Experimental neurology.

[25]  L. Uzman,et al.  The histogenesis of the mouse cerebellum as studied by its tritiated thymidine uptake , 1960, The Journal of comparative neurology.